692 filings
Page 9 of 35
SC 13G/A
BML Investment Partners, L.P.
27 Jan 22
ACELRX PHARMACEUTICALS / BML Investment Partners ownership change
2:51pm
D
TLPH
Talphera Inc.
24 Jan 22
$5.96M in equity, sold $5.16M, 32 investors
4:21pm
8-K
TLPH
Talphera Inc.
12 Jan 22
AcelRx Pharmaceuticals Announces the Closing of its Acquisition of Lowell Therapeutics
4:01pm
8-K
TLPH
Talphera Inc.
3 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:48pm
4
TLPH
Talphera Inc.
23 Nov 21
ACELRX PHARMACEUTICALS / Jill Marie Broadfoot ownership change
5:37pm
3
TLPH
Talphera Inc.
23 Nov 21
ACELRX PHARMACEUTICALS / Jill Marie Broadfoot ownership change
5:34pm
8-K
TLPH
Talphera Inc.
23 Nov 21
AcelRx Pharmaceuticals Announces the Appointment of Jill Broadfoot to its Board of Directors
5:24pm
424B5
TLPH
Talphera Inc.
15 Nov 21
Prospectus supplement for primary offering
7:31am
8-K
TLPH
Talphera Inc.
15 Nov 21
Other Events
6:53am
10-Q
2021 Q3
TLPH
Talphera Inc.
Quarterly report
15 Nov 21
6:30am
8-K
TLPH
Talphera Inc.
15 Nov 21
AcelRx Pharmaceuticals to Acquire Lowell Therapeutics
6:06am
S-8
TLPH
Talphera Inc.
18 Aug 21
Registration of securities for employees
4:01pm
8-K
TLPH
Talphera Inc.
16 Aug 21
AcelRx Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:06pm
10-Q
2021 Q2
TLPH
Talphera Inc.
Quarterly report
16 Aug 21
12:00am
8-K
TLPH
Talphera Inc.
29 Jul 21
Changes in Registrant's Certifying Accountant
4:05pm
8-K
TLPH
Talphera Inc.
14 Jul 21
AcelRx to receive up to approximately $55 million in combined up-front and sales-based milestone payments for DZUVEO licensing agreement
4:01pm
SC 13G/A
TLPH
Talphera Inc.
12 Jul 21
ACELRX PHARMACEUTICALS / BlackRock ownership change
8:29am
4
TLPH
Talphera Inc.
17 Jun 21
ACELRX PHARMACEUTICALS / MARK A WAN ownership change
5:33pm
4
TLPH
Talphera Inc.
17 Jun 21
ACELRX PHARMACEUTICALS / ADRIAN ADAMS ownership change
5:32pm
4
TLPH
Talphera Inc.
17 Jun 21
ACELRX PHARMACEUTICALS / Howard B Rosen ownership change
5:31pm